Sysmex Corporation Achieves Health Canada Approval for CN-3000 and CN-6000 Analyzers

Sysmex America, Inc., a prominent provider of diagnostic solutions, has secured a license from Health Canada for its automated blood coagulation analyzers, the CN-3000™ and CN-6000™. This milestone underscores Sysmex's commitment to enhancing lab efficiency while improving patient care.

With varying demands in the laboratory environments, these analyzers are crafted to assist healthcare professionals in diagnosing potential bleeding or clotting disorders effectively. "Timely hemostasis testing is crucial for diagnosing patients suspected of suffering from bleeding or clotting disorders," stated Dan Zortman, CEO of Sysmex America. The innovative design of the CN-Series is centered around smart workflow features that not only cater to clinical accuracy but also promotes space-efficient layouts to ease the workload of medical staff.

Key Features of CN-Series Analyzers

The Sysmex CN-3000 and CN-6000 analyzers come equipped with advanced functionalities. Their high throughput capabilities allow labs to process a large volume of tests seamlessly. Notably, the CN-Series is expandable, making it a fitting choice for laboratories looking to match the analyzers' capacity with their specific requirements. For facilities that experience high testing workloads, there is an optional sampler available, which significantly increases the sample loading capacity.

The Sysmex CN-Series serves as a strategic solution for laboratories aiming to improve operational efficiency and accuracy. It integrates cutting-edge technology designed to ensure optimal resource utilization within the clinical laboratory environment.

The Role of Sysmex in Healthcare

Sysmex America, as the regional affiliate of Kobe, Japan-based Sysmex Corporation, brings transformative testing methodologies designed to contribute to healthier lives by fostering informed decisions among healthcare professionals and their patients. The organization is recognized not only for optimizing laboratory efficiency but also for enhancing operational and financial performance in clinical settings. Forbes has honored Sysmex as one of the most innovative companies in the healthcare equipment and services category, showcasing its significant impact on the healthcare sector.

Moreover, the Center for Companies That Care has included Sysmex America on its esteemed "Honor Roll," reflecting its commitment to corporate social responsibility and excellence in providing high-quality diagnostic solutions. This recognition aligns with Sysmex’s mission to equip labs with the tools necessary for delivering reliable results, ultimately improving patient outcomes.

Healthcare professionals interested in learning more about the CN-3000 and CN-6000 systems, along with other hematology and hemostasis products, can access detailed information on Sysmex's official website.

In conclusion, Sysmex America's recent achievement in obtaining the Health Canada license for its CN Series analyzers paves the way for enhanced clinical testing capabilities in North America, marking another step forward in the pursuit of excellence in healthcare diagnostics.